Medications for Eosinophilic Esophagitis

2 results
  • dupixent - dupilumab injection, solution

    (Dupilumab)
    Sanofi-Aventis U.S. Llc
    Dupixent treats moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, COPD with eosinophilic phenotype, chronic spontaneous urticaria, bullous pemphigoid, and allergic fungal rhinosinusitis across adults and eligible pediatric patients.
  • eohilia - budesonide suspension

    (Budesonide)
    Takeda Pharmaceuticals America, Inc.
    EOHILIA is indicated for 12 weeks of treatment of eosinophilic esophagitis (EoE) in adults and pediatric patients 11 years and older. Not shown to be safe and effective beyond 12 weeks.